UPDATE 1-NMT Medical says to close trial; shares sink Jan 24, 2008
UPDATE 2-NMT Medical says to close trial; shares sink ... BANGALORE, Jan 23 (Reuters) - Medical technology company NMT Medical Inc (NMTI.O: , , ) said it would close a trial testing a new migraine treatment after only a handful of patients met enrollment requirements and the study was becoming costly, pushing shares to a three-year low. (Reuters)
Food bank breaks ground on South Bay Avenue Jun 7, 2007
claims win in patent-infringement case Boston medical technology company NMT Medical Inc. said it won an appeal in a patent-infringement lawsuit brought by Cardia Inc. of Burnsville, Minn. The US Court of Appeals for the Federal Circuit in Washington remanded the case back to a district court, which had initially ruled that NMT infringed on a Cardia patent. (Boston Globe -- Business)
Fixing Heart Holes May Ease Headaches Nov 1, 2006
But with PFO closure no longer rare, the FDA has withdrawn that special approval, urging makers NMT Medical and AGA Medical to finish their studies and tightening, slightly, how stroke patients get the devices in the meantime. Both makers have pledged to push forward, although Sommer notes that repeat-stroke sufferers often want their PFOs closed despite the controversy, and thus won't enter a study. (WRAL.com, NC)
Two heart repair devices withdrawn Oct 31, 2006
Officials at NMT Medical and AGA Medical, the device makers, could not be reached for comment late yesterday, and it could not be determined how long the devices have been available to consumers. . (Newsday -- Health)
High-Dose Statins Following a Stroke Can Prevent a Second Aug 11, 2006
Dr. Welch reported having received consulting fees from Eisai, GlaxoSmithKline, Medpointe, AstraZeneca, NMT Medical, and Ortho-McNeil; lecture fees from GlaxoSmithKline; and grant support from Pfizer. Dr. Kent reported having received grant support from Pfizer. (MedPage Today)
Study Shows Drug Reverses Heart Disease Mar 14, 2006
However, more people whose hearts were patched had a significant reduction in their number of headaches -- a result that gives hope to the device's maker, Boston-based NMT Medical Inc., which has commissioned a larger study of it in the United States. -- Doctors reported encouraging early results with the first totally absorbable stent, a tiny mesh scaffold used to prop open an artery. (Herald Sun)
The Pulse of Heart-Drug Research Mar 6, 2006
Boston-based NMT Medical () has developed a coin-sized implantable device called STARflex used to close the defect. NMT figures that, of the 28 million migraine sufferers in the U.S., about 3 million could be candidates for the STARflex. (BusinessWeek)
A hole in the heart may increase stroke risk Jan 11, 2006
PHOTO COURTESY OF NMT MEDICAL MENDING DEVICE: This device is used to seal a tiny hole in the heart, known as a patent foramen ovale, or PFO. Though the evidence remains unclear, some doctors believe a PFO may increase the risk of stroke in some patients. R E L A T E D L I N K S. (Miami.com, FL -- Health)
